1. Home
  2. RXT vs LRMR Comparison

RXT vs LRMR Comparison

Compare RXT & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$0.95

Market Cap

481.5M

Sector

Technology

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$5.05

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
LRMR
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.5M
455.8M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
RXT
LRMR
Price
$0.95
$5.05
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$1.71
$16.50
AVG Volume (30 Days)
7.4M
2.0M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
N/A
EPS
N/A
N/A
Revenue
$2,685,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.35
$1,816.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$1.61
52 Week High
$2.74
$6.42

Technical Indicators

Market Signals
Indicator
RXT
LRMR
Relative Strength Index (RSI) 34.31 57.54
Support Level $0.39 $3.14
Resistance Level $1.22 $5.37
Average True Range (ATR) 0.16 0.31
MACD -0.10 -0.02
Stochastic Oscillator 4.93 90.66

Price Performance

Historical Comparison
RXT
LRMR

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: